Predicting the Outcomes of Combination Therapy in Patients With Chronic Hepatitis C Using Artificial Neural Network

BACKGROUND: Treatment with Peginterferon Alpha-2b plus Ribavirin is the current standard therapy for chronic hepatitis C (CHC). However, many host related and viral parameters are associated with different outcomes of combination therapy. OBJECTIVES: The aim of this study was to develop an artificia...

Descripción completa

Detalles Bibliográficos
Autores principales: Sargolzaee Aval, Forough, Behnaz, Nazanin, Raoufy, Mohamad Reza, Alavian, Seyed Moayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071357/
https://www.ncbi.nlm.nih.gov/pubmed/24976838
http://dx.doi.org/10.5812/hepatmon.17028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071357/
https://www.ncbi.nlm.nih.gov/pubmed/24976838
http://dx.doi.org/10.5812/hepatmon.17028

Ejemplares similares